Page last updated: 2024-11-05

hydantoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hydantoic acid is a naturally occurring amino acid that is a precursor to the synthesis of hydantoin derivatives. It is found in various biological systems, including bacteria, fungi, and plants. The synthesis of hydantoic acid involves the enzymatic hydrolysis of allantoin, which is a product of purine metabolism. Hydantoic acid is also known to be a substrate for the enzyme hydantoinase, which converts it to hydantoin. Hydantoin derivatives have been studied for their diverse biological activities, including anticonvulsant, anti-inflammatory, and anticancer properties. The importance of hydantoic acid lies in its role as an intermediate in the metabolic pathway of purines and its potential for the synthesis of valuable pharmaceutical compounds.'

hydantoic acid: norallophanic acid; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10020
CHEBI ID133351
SCHEMBL ID289921
MeSH IDM0057433

Synonyms (49)

Synonym
n-carbamoylglycine ,
carbamoylglycine
462-60-2
glycoluric acid
nsc49417
acetic acid, [(aminocarbonyl)amino]-
glycine, n-(aminocarbonyl)-
urea, (carboxymethyl)-
hydantoic acid
nsc-49417
acetic acid, ureido-
glycine, n-carbamoyl-
inchi=1/c3h6n2o3/c4-3(8)5-1-2(6)7/h1h2,(h,6,7)(h3,4,5,8
OPREA1_578490
brn 1812022
ccris 6533
nsc 49417
cb 1636
einecs 207-328-5
n-carbamylglycine
acetic acid, ((aminocarbonyl)amino)-
carbomoylglycine
CHEBI:133351
AKOS000264528
2-(carbamoylamino)acetic acid
n-carboxymethylurea
H0655
q4f314u63k ,
4-04-00-02411 (beilstein handbook reference)
unii-q4f314u63k
[(aminocarbonyl)amino]acetic acid
EN300-10397
FT-0632170
ureidoacetic acid
n-carbamyl glycine
SCHEMBL289921
AB00981907-01
DTXSID7060045
n-(carboxymethyl)urea
2-ureidoacetic acid
mfcd00047876
Z57009586
STL553754
CS-0204817
Q27286991
AT23074
hydantoinsa currencyure
AS-56566
SY051314
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
rat metaboliteAny mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus).
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
N-acylglycineAn N-acyl-amino acid in which amino acid specified is glycine.
ureas
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.21 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]